Introduction Troponin is an integral component of the evaluation for acute coronary
syndrome (ACS) and occlusion myocardial infarction (OMI). However, troponin may be …

Because of its high prevalence, chronic kidney disease (CKD) remains a major health
hazard throughout the world. Patients with CKD have a high prevalence and incidence of …

Background and Objectives: This study evaluated the clinical characteristics of the acute
coronary syndromes (ACS) in chronic kidney disease (CKD) patients and established …

Abstract Background and Aims Contrast-induced nephropathy (CIN), also known as contrast-
associated acute kidney injury (CA-AKI) underlies a significant proportion of the morbidity …

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is the
cornerstone of pharmacologic management of patients with acute coronary syndrome (ACS) …

Aims To examine associations of the gut microbial metabolite trimethylamine-N-oxide
(TMAO) and its precursors with risk of cardiovascular events in acute coronary syndrome …

Chronic kidney disease (CKD) has a very well-established link with cardiovascular disease.
Below stage 3 CKD (glomerular filtration rate< 60 mL/min), there is a progressive increase in …

This study aims to evaluate potentially appropriate antiplatelet therapy in patients with
chronic kidney disease. A systematic analysis was conducted to identify the clinical …

Introduction Coexistence of chronic kidney disease (CKD) in the case of acute coronary
syndromes (ACS) significantly worsens the outcomes. Aim The aim of our study was to …

Renal dysfunction is frequent in patients with non-ST-segment elevation acute coronary
syndrome (NSTE-ACS). Chronic kidney disease (CKD) is associated with very poor …